NCT06152523 2026-04-06
MONAMI
Assistance Publique - Hôpitaux de Paris
Phase 2 Withdrawn
Clinical Trials
317 trialsNCT07222358 2026-04-06
Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery
St. Jude Children's Research Hospital
Withdrawn
NCT07484282 2026-04-03
Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer
National Institutes of Health Clinical Center (CC)
Withdrawn
NCT07313891 2026-03-17
BOOST
Relmada Therapeutics, Inc.
Phase 3 Withdrawn
NCT07342517 2026-03-17
RESCUE
Relmada Therapeutics, Inc.
Phase 3 Withdrawn
NCT06240377 2026-03-09
Effectiveness of NMP and TDCS vs Pharmacological Treatment in Cancer Patients With Lower Limb Pain
Universidad Europea de Canarias
Phase NA Withdrawn
NCT06240390 2026-03-09
Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain
Universidad Europea de Canarias
Phase NA Withdrawn
NCT04482933 2026-02-10
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Pediatric Brain Tumor Consortium
Phase 2 Withdrawn
NCT06922825 2026-01-21
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03135743 2026-01-16
LYMPHOSYNCHRO
Centre Hospitalier Universitaire, Amiens
Withdrawn
NCT07071909 2026-01-06
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Withdrawn
NCT07293520 2025-12-26
Improving Consent Experiences in Clinical Trials
Washington University School of Medicine
Phase NA Withdrawn
NCT04020029 2025-12-19
Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer
Stanford University
Phase NA Withdrawn
NCT06116578 2025-12-01
NeoSarc
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Withdrawn
NCT04036045 2025-10-06
Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity
Connecticut Children's Medical Center
Withdrawn
NCT06690281 2025-09-11
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT05052632 2025-08-13
Evaluating a New Gonadotoxic Risk Stratification System
University of Colorado, Denver
Withdrawn
NCT05000905 2025-08-06
Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training
University of California, San Francisco
Phase NA Withdrawn
NCT05917990 2025-07-28
Dyadic Text-Messaging Micro-Intervention
Duke University
Phase NA Withdrawn
NCT06161558 2025-07-16
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn
NCT05257707 2025-07-09
MOCA
Centre Hospitalier Universitaire de Besancon
Phase NA Withdrawn
NCT02077621 2025-06-04
Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer
PhytoHealth Corporation
Phase 2 Withdrawn
NCT06390657 2025-05-11
S-C-PATHY
EBG MedAustron GmbH
Withdrawn
NCT02591433 2025-05-01
JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer
Thomas Jefferson University
Phase NA Withdrawn
NCT05900908 2025-04-10
PATHWAyS
GT Medical Technologies, Inc.
Phase 4 Withdrawn
NCT06351306 2025-03-24
DEC-C and Thioguanine for R/R AML
Columbia University
Phase 2 Withdrawn
NCT03916783 2025-02-27
Suubi4Cancer: Improving Access to Pediatric Cancer Services and Treatment Adherence Among Children Living With HIV/AIDS
Washington University School of Medicine
Phase NA Withdrawn
NCT02743546 2025-02-03
Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma
Janssen Research & Development, LLC
Phase 1 Withdrawn
NCT04271436 2025-01-07
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Washington University School of Medicine
Phase 2 Withdrawn
NCT06537063 2025-01-07
Detection of G-quadruplex DNA Methylation in Cancer
Zhongnan Hospital
Withdrawn
NCT04260230 2024-12-30
REACT
The Christie NHS Foundation Trust
Phase NA Withdrawn
NCT05640115 2024-12-19
Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
University of Chicago
Phase EARLY_PHASE1 Withdrawn
NCT06654258 2024-11-26
Supporting Spiritual Wellbeing in Young Adults With Cancer Using a Digital Health Approach: A Feasibility Study
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT06023368 2024-11-14
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
University of Kentucky
Phase 4 Withdrawn
NCT06377202 2024-11-07
Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies
Verismo Therapeutics
Withdrawn
NCT05589857 2024-10-23
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT04135326 2024-10-09
Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT06372574 2024-09-03
A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors
Genentech, Inc.
Phase 1 Withdrawn
NCT02249520 2024-08-21
Calibration of MR and PET-MR Imaging Protocols at RIC
Cedars-Sinai Medical Center
Phase NA Withdrawn
NCT05112458 2024-08-15
Cope 360 App for Caregivers of Children With Cancer
Indiana University
Phase NA Withdrawn
NCT04023240 2024-08-12
68-Ga-FAPI PET Imaging in Malignancy
Stanford University
Phase 2 Withdrawn
NCT05423808 2024-08-12
GerOnTe-TWOBE
Universitaire Ziekenhuizen KU Leuven
Phase NA Withdrawn
NCT05898828 2024-08-05
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Withdrawn
NCT06335745 2024-08-05
PediCARE Health Equity Intervention in High-Risk Neuroblastoma
Dana-Farber Cancer Institute
Phase NA Withdrawn
NCT04508855 2024-07-30
MAFIC
AHEPA University Hospital
Withdrawn
NCT05408195 2024-06-28
ONCO-CHATBOT
University Hospital, Toulouse
Phase NA Withdrawn
NCT02840227 2024-06-20
The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections
The Cleveland Clinic
Phase NA Withdrawn
NCT05602896 2024-06-14
Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program
Washington University School of Medicine
Phase NA Withdrawn
NCT05153304 2024-06-10
Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
University of California, San Diego
Phase 1/2 Withdrawn
NCT03044795 2024-05-03
REPAIR
University Medical Center Groningen
Phase 2 Withdrawn